Diseases of liporegulation: new perspective on obesity and related disorders.
about
Activation of Wnt/beta-catenin signaling increases insulin sensitivity through a reciprocal regulation of Wnt10b and SREBP-1c in skeletal muscle cellsIntimal redox stress: accelerated atherosclerosis in metabolic syndrome and type 2 diabetes mellitus. Atheroscleropathy.Role of a critical visceral adipose tissue threshold (CVATT) in metabolic syndrome: implications for controlling dietary carbohydrates: a reviewLeptin's role in lipodystrophic and nonlipodystrophic insulin-resistant and diabetic individualsRegulation of lipid stores and metabolism by lipophagyAttenuation of renovascular damage in Zucker diabetic fatty rat by NWT-03, an egg protein hydrolysate with ACE- and DPP4-inhibitory ActivityNutrition, insulin resistance and dysfunctional adipose tissue determine the different components of metabolic syndromeDistinct transcriptional regulation of long-chain acyl-CoA synthetase isoforms and cytosolic thioesterase 1 in the rodent heart by fatty acids and insulinThe extreme C terminus of rat liver carnitine palmitoyltransferase I is not involved in malonyl-CoA sensitivity but in initial protein foldingAcquired obesity is associated with changes in the serum lipidomic profile independent of genetic effects--a monozygotic twin study.Protein kinase B/Akt prevents fatty acid-induced apoptosis in pancreatic beta-cells (INS-1).High-throughput screening for fatty acid uptake inhibitors in humanized yeast identifies atypical antipsychotic drugs that cause dyslipidemias.Fat in liver/muscle correlates more strongly with insulin sensitivity in rats than abdominal fat.Liver and adipose expression associated SNPs are enriched for association to type 2 diabetesIdentification of a novel sn-glycerol-3-phosphate acyltransferase isoform, GPAT4, as the enzyme deficient in Agpat6-/- mice.Fatty diabetic lung: altered alveolar structure and surfactant protein expressionEffect of renal lipid accumulation on proximal tubule Na+/H+ exchange and ammonium secretion.Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes.Postprandial lysophospholipid suppresses hepatic fatty acid oxidation: the molecular link between group 1B phospholipase A2 and diet-induced obesity.AMP kinase and malonyl-CoA: targets for therapy of the metabolic syndrome.Insulin resistance reduces arterial prostacyclin synthase and eNOS activities by increasing endothelial fatty acid oxidation.Exercise-induced modulation of cardiac lipid content in healthy lean young men.Hyperglycemia in rodent models of type 2 diabetes requires insulin-resistant alpha cells.Physiological roles of group X-secreted phospholipase A2 in reproduction, gastrointestinal phospholipid digestion, and neuronal function.Epidermal fatty acid-binding protein protects nerve growth factor-differentiated PC12 cells from lipotoxic injuryActivation of peroxisome proliferator-activated receptor-alpha stimulates both differentiation and fatty acid oxidation in adipocytesRenal lipid metabolism and lipotoxicity.Reduction of renal triglyceride accumulation: effects on proximal tubule Na+/H+ exchange and urinary acidification.Therapeutic potential of histamine H3 receptor agonist for the treatment of obesity and diabetes mellitus.Inhibitory effects of grape skin extract and resveratrol on fatty acid synthase.Lactosylceramide promotes hypertrophy through ROS generation and activation of ERK1/2 in cardiomyocytes.AMPK as a metabolic switch in rat muscle, liver and adipose tissue after exercise.Genetic manipulation of cardiac Hsp72 levels does not alter substrate metabolism but reveals insights into high-fat feeding-induced cardiac insulin resistanceRoles of Sphingolipid Metabolism in Pancreatic β Cell Dysfunction Induced by Lipotoxicity.A Difference in Fatty Acid Composition of Isocaloric High-Fat Diets Alters Metabolic Flexibility in Male C57BL/6JOlaHsd Mice.Diabetes, lipids, and adipocyte secretagogues.Signalling components involved in contraction-inducible substrate uptake into cardiac myocytes.Loss of leptin actions in obesity: two concepts with cardiovascular implications.AICAR and Metformin Exert AMPK-dependent Effects on INS-1E Pancreatic β-cell Apoptosis via Differential Downstream Mechanisms.Stearoyl-CoA desaturase as a new drug target for obesity treatment.
P2860
Q21142682-04566AD5-A721-486D-8A90-A5001A733C76Q24796491-1364C326-B0AA-4D55-910E-39146A3C2C93Q24801508-C636A437-B35F-4CD8-A077-A55778DCAA2BQ26859118-6363E1CE-F306-40EA-9C7C-CAA56F831A37Q27009151-D0D41D61-0D0C-42E0-872A-EFE2BFD70B39Q27315825-22A424A7-5F7A-4948-AB0A-E726928AAF48Q28079661-74A51EE6-667A-45C6-92BE-B15C43957D3AQ28574224-3D044658-AC04-43B4-BE4D-BE0903F10DF5Q28577659-6D7919C3-7C01-4EB3-BBE2-307206A8D621Q30829796-71E75699-74C4-4150-B6F4-548023CC5F99Q33184955-A06DAD06-941B-4CC4-BD2C-A25758A7D6A3Q33302249-A7FE1614-DE43-4292-922F-C467D99B497EQ33379065-C19DEDF6-C040-4FD2-B16D-DA566D132F7DQ33576732-D482423E-9993-4993-8926-DA6688E6627AQ33642258-59C7491D-C7B9-40F4-8963-7E93FE4D2F5CQ33728236-20698DF4-08EB-4160-80D2-F1B437DCD4F6Q33818281-A22EF7F6-38DA-4981-9D9A-AA4FFE2389F5Q33918445-81E50B57-D61B-4D1C-9CBB-3CBBD17B8F73Q33919454-419C4AA9-0941-4445-8A90-96364F3440F9Q34310675-A3174CCF-0B73-4C9E-AF6A-10C131F87671Q34435166-A28AFDB9-3314-41FF-A751-E4976F1803EFQ34548132-B64577E1-50B4-4312-92B9-36819DF2C238Q34583696-F7EF8CA8-760C-43D0-9684-C5CAF587E32EQ34719758-EB805A33-965A-4A7B-8789-611CC8AE94B7Q34734555-C6534AE1-147D-4723-9144-A37EE6DDFA22Q34776235-0990F2A2-40D9-4554-B060-A75E0AD7A7E5Q34825296-62674B11-1217-4655-828F-621E30CC76FDQ34998284-643DC1F3-32BE-467B-9679-9977C140C1F4Q35017231-09C47A30-8EF0-405D-AC2F-E1662012E3B1Q35068232-0B3CD59E-F9BA-458F-9B1C-16DD77255A11Q35128221-E16DC121-CA13-4870-8E99-D7A0CB6478BCQ35178619-9DC152DE-0F8C-462C-9EA0-1A4D9366DE86Q35529105-4FB6DF8A-439D-4DF6-8186-C45110742B36Q35667288-20533435-F82A-4B22-889F-56C841B03A17Q35670661-E0489B9F-91C9-4483-9695-BD3380615AD8Q35723496-5149C0A8-5F35-4A9A-8F01-E124C4CAACABQ35855934-C6C1C7D9-67F5-4DD6-920D-2A9CC5952AF8Q36035803-F5ED71A2-45BB-4711-9FDB-9EDBD4A253C1Q36090995-4DCEE595-78ED-4C7D-BE4F-743B5472C231Q36100781-A6D5B9AD-148D-4B43-B6D5-479943ED4518
P2860
Diseases of liporegulation: new perspective on obesity and related disorders.
description
2001 nî lūn-bûn
@nan
2001 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Diseases of liporegulation: new perspective on obesity and related disorders.
@ast
Diseases of liporegulation: new perspective on obesity and related disorders.
@en
Diseases of liporegulation: new perspective on obesity and related disorders.
@nl
type
label
Diseases of liporegulation: new perspective on obesity and related disorders.
@ast
Diseases of liporegulation: new perspective on obesity and related disorders.
@en
Diseases of liporegulation: new perspective on obesity and related disorders.
@nl
prefLabel
Diseases of liporegulation: new perspective on obesity and related disorders.
@ast
Diseases of liporegulation: new perspective on obesity and related disorders.
@en
Diseases of liporegulation: new perspective on obesity and related disorders.
@nl
P356
P1433
P1476
Diseases of liporegulation: new perspective on obesity and related disorders.
@en
P304
P356
10.1096/FJ.00-0590
P407
P577
2001-02-01T00:00:00Z